$5.62 0.04 (+0.72%)
11/20/2009 4:00 PM

Maxygen, Inc. (MAXY)

CAPS Rating: 2 out of 5

A biotechnology company committed to the discovery and development of improved next-generation protein pharmaceuticals for the treatment of disease and serious medical conditions.

Featured Broker Partners